Terns Pharmaceuticals Inc (NASDAQ:TERN) price on Thursday, April 10, fall -6.96% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.14.
A look at the stock’s price movement, the close in the last trading session was $2.30, moving within a range at $2.065 and $2.41. The beta value (5-Year monthly) was -0.141. Turning to its 52-week performance, $11.40 and $1.87 were the 52-week high and 52-week low respectively. Overall, TERN moved -41.53% over the past month.
Terns Pharmaceuticals Inc’s market cap currently stands at around $186.81 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-19.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TERN is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 2 analyst(s) rate the stock as a Hold, 3 recommend TERN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TERN’s current price about -23.49% and -39.07% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 29.38, while 7-day volatility ratio is 16.00% and 9.43% in the 30-day chart. Further, Terns Pharmaceuticals Inc (TERN) has a beta value of -0.09, and an average true range (ATR) of 0.26. Analysts have given the company’s stock an average 52-week price target of $20, forecast between a low of $20 and high of $20. Looking at the price targets, the low is -834.58% off current price level while to achieve the yearly target high, price needs to move -834.58%. Nonetheless, investors will most likely welcome a -834.58% jump to $20 which is the analysts’ median price.
If we refocus on Terns Pharmaceuticals Inc (NASDAQ:TERN), historical trading data shows that trading volumes averaged 1.58 over the past 10 days and 1.42 million over the past 3 months. The company’s latest data on shares outstanding shows there are 87.13 million shares.
The 25.20% of Terns Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 78.65% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.95 million on 2025-03-14, giving us a short ratio of 5.57. The data shows that as of 2025-03-14 short interest in Terns Pharmaceuticals Inc (TERN) stood at 747.0000000000001 of shares outstanding, with shares short rising to 5.92 million registered in 2025-02-14. Current price change has pushed the stock -61.37% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TERN stock continues to rise going into the next quarter.
